These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9722128)

  • 61. The use of fluoxetine (Prozac) in premenstrual syndrome: is the incidence of sexual dysfunction and anorgasmia acceptable?
    Oláh KS
    J Obstet Gynaecol; 2002 Jan; 22(1):81-3. PubMed ID: 12521737
    [No Abstract]   [Full Text] [Related]  

  • 62. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study.
    Berger CP; Presser B
    Obstet Gynecol; 1994 Sep; 84(3):379-85. PubMed ID: 8058235
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
    Steiner M; Pearlstein T
    J Clin Psychiatry; 2000; 61 Suppl 12():17-21. PubMed ID: 11041380
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
    Kornstein SG; Pearlstein TB; Fayyad R; Farfel GM; Gillespie JA
    J Clin Psychiatry; 2006 Oct; 67(10):1624-32. PubMed ID: 17107257
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
    Steinberg EM; Cardoso GM; Martinez PE; Rubinow DR; Schmidt PJ
    Depress Anxiety; 2012 Jun; 29(6):531-40. PubMed ID: 22565858
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.
    Freeman EW; Rickels K; Sondheimer SJ; Wittmaack FM
    J Clin Psychiatry; 1996 Jan; 57(1):7-11. PubMed ID: 8543554
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of fluoxetine on menstrual cycle length in women with premenstrual dysphoria.
    Steiner M; Lamont J; Steinberg S; Stewart D; Reid R; Streiner D
    Obstet Gynecol; 1997 Oct; 90(4 Pt 1):590-5. PubMed ID: 9380321
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
    Jarvis CI; Lynch AM; Morin AK
    Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
    Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
    JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Psychiatric and psychological aspects of premenstrual syndrome].
    Limosin F; Ades J
    Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Venlafaxine in the treatment of premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Yonkers KA; Kunz NR; McPherson M; Upton GV
    Obstet Gynecol; 2001 Nov; 98(5 Pt 1):737-44. PubMed ID: 11704162
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of premenstrual dysphoria with alprazolam. A controlled study.
    Harrison WM; Endicott J; Nee J
    Arch Gen Psychiatry; 1990 Mar; 47(3):270-5. PubMed ID: 2407209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study.
    De Souza MC; Walker AF; Robinson PA; Bolland K
    J Womens Health Gend Based Med; 2000 Mar; 9(2):131-9. PubMed ID: 10746516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sertraline for premenstrual dysphoric disorder.
    Cohen LS
    JAMA; 1998 Feb; 279(5):357-8. PubMed ID: 9459467
    [No Abstract]   [Full Text] [Related]  

  • 76. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
    Pearlstein TB; Stone AB; Lund SA; Scheft H; Zlotnick C; Brown WA
    J Clin Psychopharmacol; 1997 Aug; 17(4):261-6. PubMed ID: 9241004
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant.
    Freeman EW; Rickels K; Arredondo F; Kao LC; Pollack SE; Sondheimer SJ
    J Clin Psychopharmacol; 1999 Feb; 19(1):3-8. PubMed ID: 9934936
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
    Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
    Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effects of vitamin B6 supplementation on premenstrual symptoms.
    Kendall KE; Schnurr PP
    Obstet Gynecol; 1987 Aug; 70(2):145-9. PubMed ID: 3299182
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The premenstrual syndrome].
    van der Leij F; Schultz WC; van de Wiel H; van Leeuwen JH
    Ned Tijdschr Geneeskd; 2010; 154():A1341. PubMed ID: 20719012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.